Skip to menu Skip to content Skip to footer
Professor Michael O'Sullivan
Professor

Michael O'Sullivan

Email: 
Phone: 
+61 7 334 65503

Overview

Background

Overview

Professor Michael O’Sullivan is a neuroscientist, neurologist and group leader at the Institute for Molecular Bioscience (IMB). His main research interest is the neurobiology of brain injury, with an emphasis on mechanisms of resilience and recovery of the brain after injury. His previous work has developed understanding in two broad areas:

  • The cognitive neuroscience of memory and cognitive control – and how distributed and dynamic networks in the brain support these functions, which are often affected by injury.
  • How injury alters network structure and function leading to symptoms in day-to-day life - and intrinsic mechanisms of neural adaptation that modulate the effect of injury

At the Institute for Molecular Bioscience, O’Sullivan is building a research program on cellular and molecular events that influence adaptation and recovery, including the role of innate immunity and glial cells. This program includes novel approaches to neuroprotection and the role of astrocytes as key regulators of glutamate and neuroinflammation. A major theme is identification of therapeutic targets, and evaluation of disease progression or treatment response in vivo, using advanced human imaging with MRI, PET and novel radiotracers. In addition to his Institute work, O’Sullivan leads clinical and biomarker projects in stroke and traumatic brain injury and is a member of the NHMRC Centre for Research Excellence in vascular mechanisms of cognitive impairment.

The group is at the forefront in the application of advanced techniques to investigate brain structure and function in vivo, including diffusion MRI and tractography, the use of functional MRI and EEG to examine to examine dynamic network interactions, and PET to examine neurochemistry.

Supervision

Professor O’Sullivan supervises PhD projects across multiple research areas, including clinical science, cognitive neuroscience, animal models and computational neuroscience (such as machine learning and deep learning algorithms for diagnosis and prediction of prognosis). Expressions of interest from potential PhD and honours students are welcome.

Availability

Professor Michael O'Sullivan is:
Available for supervision
Media expert

Research impacts

As a practising clinican, Professor O’Sullivan has a strong interest in translation. Through senior roles in health care - such as Director of Research and Implementation at the Royal Brisbane and Women's Hospital - he has been a champion for translation, innovation in health care and health-academic partnerships to deliver better outcomes for patients.

Internationally, he has led efforts to integrate cognition in stroke recovery research (he chaired the Cognition Working Group of the international Stroke Rehabilitation and Recovery Roundtable).

Professor O'Sullivan co-chairs the Local Organising Commitee for Brain and Brain PET 2023, a major international meeting to be held in Brisbane.

O'Sullivan is an established independent expert in brain injury in sport and authored an independent review commissioned by the Australian Football League in 2022.

Works

Search Professor Michael O'Sullivan’s works on UQ eSpace

89 works between 2000 and 2025

81 - 89 of 89 works

2004

Journal Article

Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease

Hassan, A., Gormley, K., O'Sullivan, M., Knight, J., Sham, P., Vallance, P., Bamford, J. and Markus, Hugh (2004). Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease. Stroke, 35 (3), 654-659. doi: 10.1161/01.STR.0000117238.75736.53

Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease

2004

Journal Article

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

Hassan, Ahamad, Hunt, Beverley J., O'Sullivan, Michael, Bell, Rachel, D'Souza, Reuben, Jeffery, Steve, Bamford, John M. and Markus, Hugh S. (2004). Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain, 127 (1), 212-219. doi: 10.1093/brain/awh023

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

2003

Journal Article

Frequency of subclinical lacunar infarcts in ischemic leukoaraiosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

O'Sullivan, Michael, Rich, Philip M., Barrick, Thomas R., Clark, Christopher A. and Markus, Hugh S. (2003). Frequency of subclinical lacunar infarcts in ischemic leukoaraiosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. American Journal of Neuroradiology, 24 (7), 1348-1354.

Frequency of subclinical lacunar infarcts in ischemic leukoaraiosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

2003

Journal Article

Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis

Hassan, Ahamad, Hunt, Beverley J., O'Sullivan, Michael, Parmar, Kiran, Bamford, John M., Briley, Dennis, Brown, Martin M., Thomas, Dafydd J. and Markus, Hugh S. (2003). Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain, 126 (2), 424-432. doi: 10.1093/brain/awg040

Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis

2002

Journal Article

Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis

O'Sullivan, M., Lythgoe, D. J., Pereira, A. C., Summers, P. E., Jarosz, J. M., Williams, S. C.R. and Markus, H. S. (2002). Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology, 59 (3), 321-326. doi: 10.1212/WNL.59.3.321

Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis

2001

Journal Article

Normal-appearing white matter in ischemic leukoaraiosis: A diffusion tensor MRI study

O'Sullivan, M., Summers, P. E., Jones, D. K., Jarosz, J. M., Williams, S. C.R. and Markus, H. S. (2001). Normal-appearing white matter in ischemic leukoaraiosis: A diffusion tensor MRI study. Neurology, 57 (12), 2307-2310. doi: 10.1212/WNL.57.12.2307

Normal-appearing white matter in ischemic leukoaraiosis: A diffusion tensor MRI study

2001

Journal Article

Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline

O'Sullivan, Mike, Jones, D. K., Summers, P. E., Morris, R. G., Williams, S. C.R. and Markus, H. S. (2001). Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology, 57 (4), 632-638. doi: 10.1212/WNL.57.4.632

Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline

2001

Journal Article

MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL

O'Sullivan, Michael, Jarosz, J. M., Martin, R. J., Deasy, N., Powell, J. F. and Markus, H. S. (2001). MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology, 56 (5), 628-634. doi: 10.1212/WNL.56.5.628

MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL

2000

Journal Article

Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI

Markus, H. S., Lythgoe, D. J., Ostegaard, L., O'Sullivan, M. and Williams, S. C.R. (2000). Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. Journal of Neurology Neurosurgery and Psychiatry, 69 (1), 48-53. doi: 10.1136/jnnp.69.1.48

Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI

Funding

Current funding

  • 2021 - 2026
    Vascular Contributions to Dementia (VCD-CRE) - a transformative approach to reducing the burden of cognitive disorders (NHMRC CRE administered by UNSW)
    University of New South Wales
    Open grant
  • 2021 - 2026
    Clinical trial to determine the effects of statins on cognition: STAREE-Mind (NHRMC Clinical Trials and Cohort Studies Grant administered by Monash University)
    Monash University
    Open grant
  • 2018 - 2026
    Apathy, motivation and cognitive control after stroke
    Research Donation Generic
    Open grant

Past funding

  • 2022 - 2024
    Brain injury in intimate partner violence: Insight into a silent pandemic (NHMRC Ideas Grant administered by Monash University).
    Monash University
    Open grant
  • 2021 - 2024
    A Novel PET Imaging Market of Astrocytes and Glutamate Reuptake in Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2019 - 2020
    Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)
    The George Institute for Global Health
    Open grant

Supervision

Availability

Professor Michael O'Sullivan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    The impact of occupational performance on recovery and burden of post concussion syndrome(PCCS) after mild traumatic brain injury

    Associate Advisor

    Other advisors: Professor Jennifer Fleming

Completed supervision

Media

Enquiries

Contact Professor Michael O'Sullivan directly for media enquiries about:

  • ageing
  • cognitive decline
  • diffusion MRI
  • functional MRI
  • neurologist
  • resilience
  • restoration
  • STRATEGIC
  • stroke
  • tractography

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au